Inventor · disambiguated record
Neil T. Parkin
Also filed as: PARKIN NEIL T
22 granted patents·19 pending applications·504 citations·filing 1995–2017
96Inventor score
Top patents by PatentIndex Score
41 records- 0197US6322967B1Recombinant tryptophan mutants of influenzaAVIRON INC·Filed 2000·Granted Nov 27, 2001·105 cites·22 claims
- 0293US7169551B2Methods of evaluating viral entry inhibitors using patient derived envelope protein constructsMONOGRAM BIOSCIENCES INC·Filed 2005·Granted Jan 30, 2007·27 cites·71 claims
- 0392US5690937ATemperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 geneAVIRON INC·Filed 1995·Granted Nov 25, 1997·108 cites·4 claims
- 0491US10202658B2Methods for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitorsPARKIN NEIL T·Filed 2012·Granted Feb 12, 2019·71 cites·12 claims
- 0588US7097970B2Methods of evaluating viral entry inhibitors using patient derived envelope protein constructsMONOGRAM BIOSCIENCES INC·Filed 2001·Granted Aug 29, 2006·41 cites·36 claims
- 0687US6090391ARecombinant tryptophan mutants of influenzaAVIRON INC·Filed 1996·Granted Jul 18, 2000·61 cites·21 claims
- 0786US7247439B1Method of evaluating a patient antibody response to envelope proteins of a virusMONOGRAM BIOSCIENCES INC·Filed 2002·Granted Jul 24, 2007·17 cites·31 claims
- 0885US7235356B2Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructsMONOGRAM BIOSCIENCES INC·Filed 2005·Granted Jun 26, 2007·9 cites·20 claims
- 0985US6869759B1Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSVIROLOGIC INC·Filed 2000·Granted Mar 22, 2005·14 cites·12 claims
- 1078US7384734B2Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitorsMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Jun 10, 2008·6 cites·19 claims
- 1178US6974686B2Recombinant tryptophan mutants of influenzaMEDIMMUNE VACCINES INC·Filed 2002·Granted Dec 13, 2005·3 cites·25 claims
- 1275US7138231B2Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSMONOGRAM BIOSCIENCES INC·Filed 2001·Granted Nov 21, 2006·3 cites·83 claims
- 1373US9841425B2Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysMONOGRAM BIOSCIENCES INC·Filed 2015·Granted Dec 12, 2017·1 cites·27 claims
- 1473US7186506B1Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSMONOGRAM BIOSCIENCES INC·Filed 2000·Granted Mar 6, 2007·2 cites·8 claims
- 1572US8071284B2Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugsGUPTA SOUMI·Filed 2006·Granted Dec 6, 2011·2 cites·15 claims
- 1672US7993824B2Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitorsMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Aug 9, 2011·2 cites·35 claims
- 1768US6843996B1Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutationMEDIMMUNE VACCINES INC·Filed 1999·Granted Jan 18, 2005·30 cites·9 claims
- 1863US9175355B2Methods for determining the presence of antibodies blocking viral infectionRICHMAN DOUGLAS·Filed 2009·Granted Nov 3, 2015·0 cites·23 claims
- 1963US2019025305A1Compositions and Methods for Evaluating Viral Receptor/Co-Receptor Usage and Inhibitors of Virus Entry Using Recombinant Virus AssaysMONOGRAM BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2063US2008044810A1Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSVIROLOGIC INC·Filed 2007·Application pending·0 cites
- 2158US2006035249A1Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSVIROLOGIC INC·Filed 2005·Application pending·0 cites
- 2257US6528064B2Recombinant trytophan mutants of influenzaMED IMMUNE VACCINES INC·Filed 2001·Granted Mar 4, 2003·0 cites·15 claims
- 2356US2003108857A1Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSFiled 2001·Application pending·0 cites
- 2454US2006094020A1Methods and compositions for determining resistance or susceptibility of HIV-1 to stavudinePARKIN NEIL T·Filed 2004·Application pending·0 cites
- 2554US2011229906A1Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSPARKIN NEIL T·Filed 2010·Application pending·0 cites
- 2654US2007099296A1Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugsMONOGRAM BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 2754US2010227313A1Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Protease Inhibitor TreatmentLAB CORP AMERICA HOLDINGS·Filed 2008·Application pending·0 cites
- 2853US7553618B2Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavirMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Jun 30, 2009·2 cites·6 claims
- 2952US2009087841A1Methods and compositions for determining resistance of hiv-1 to protease inhibitorsMONOGRAM BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 3052US2004063191A1Compositions and methods for determining the replication capacity of a pathogenic virusFiled 2003·Application pending·0 cites
- 3152US2010070184A1Method for determining resistance of hiv to protease inhibitor treatmentMONOGRAM BIOSCIENCES INC·Filed 2007·Application pending·0 cites
- 3250US8178291B2Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitorsPARKIN NEIL T·Filed 2006·Granted May 15, 2012·0 cites·15 claims
- 3348US2005214743A1Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysVIROLOGIC INC·Filed 2003·Application pending·0 cites
- 3448US2004110125A1Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysFiled 2002·Application pending·0 cites
- 3547US8637252B2Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugsGUPTA SOUMI·Filed 2011·Granted Jan 28, 2014·0 cites·11 claims
- 3647US2008293038A1Method for Determining Resistance of Hiv to Nucleoside Reverse Transcriptase Inhibitor TreatmentPARKIN NEIL T·Filed 2006·Application pending·0 cites
- 3746US2005214749A1Method for determining reduced susceptibility of HIV to protease inhibitor treatmentCHAPPEY COLOMBE·Filed 2005·Application pending·0 cites
- 3844US2003028011A1Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugsFiled 2002·Application pending·0 cites
- 3944US2002094522A1Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSFiled 2001·Application pending·0 cites
- 4041US2005214750A1Compositions and methods for determining the replication capacity of a pathogenic virusVIROLOGIC INC·Filed 2005·Application pending·0 cites
- 4130US2002034732A1Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screeningFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →